rs33998267

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_000081.4(LYST):​c.9C>T​(p.Thr3Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0154 in 1,611,378 control chromosomes in the GnomAD database, including 220 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.011 ( 8 hom., cov: 32)
Exomes 𝑓: 0.016 ( 212 hom. )

Consequence

LYST
NM_000081.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.148

Publications

6 publications found
Variant links:
Genes affected
LYST (HGNC:1968): (lysosomal trafficking regulator) This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013]
LYST Gene-Disease associations (from GenCC):
  • Chediak-Higashi syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • attenuated Chédiak-Higashi syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 1-235830409-G-A is Benign according to our data. Variant chr1-235830409-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 254942.
BP7
Synonymous conserved (PhyloP=-0.148 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0115 (1745/151914) while in subpopulation AMR AF = 0.0184 (280/15250). AF 95% confidence interval is 0.0166. There are 8 homozygotes in GnomAd4. There are 794 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LYSTNM_000081.4 linkc.9C>T p.Thr3Thr synonymous_variant Exon 3 of 53 ENST00000389793.7 NP_000072.2 Q99698-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LYSTENST00000389793.7 linkc.9C>T p.Thr3Thr synonymous_variant Exon 3 of 53 5 NM_000081.4 ENSP00000374443.2 Q99698-1

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1746
AN:
151796
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00283
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0184
Gnomad ASJ
AF:
0.0185
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00312
Gnomad FIN
AF:
0.00723
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0168
Gnomad OTH
AF:
0.0226
GnomAD2 exomes
AF:
0.0115
AC:
2859
AN:
249432
AF XY:
0.0116
show subpopulations
Gnomad AFR exome
AF:
0.00229
Gnomad AMR exome
AF:
0.0118
Gnomad ASJ exome
AF:
0.0180
Gnomad EAS exome
AF:
0.000164
Gnomad FIN exome
AF:
0.00704
Gnomad NFE exome
AF:
0.0171
Gnomad OTH exome
AF:
0.0155
GnomAD4 exome
AF:
0.0158
AC:
23033
AN:
1459464
Hom.:
212
Cov.:
30
AF XY:
0.0154
AC XY:
11159
AN XY:
726150
show subpopulations
African (AFR)
AF:
0.00240
AC:
80
AN:
33348
American (AMR)
AF:
0.0129
AC:
576
AN:
44558
Ashkenazi Jewish (ASJ)
AF:
0.0184
AC:
479
AN:
26082
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39632
South Asian (SAS)
AF:
0.00295
AC:
254
AN:
86012
European-Finnish (FIN)
AF:
0.00806
AC:
430
AN:
53378
Middle Eastern (MID)
AF:
0.00991
AC:
57
AN:
5752
European-Non Finnish (NFE)
AF:
0.0182
AC:
20201
AN:
1110408
Other (OTH)
AF:
0.0158
AC:
952
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
984
1968
2952
3936
4920
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0115
AC:
1745
AN:
151914
Hom.:
8
Cov.:
32
AF XY:
0.0107
AC XY:
794
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.00282
AC:
117
AN:
41428
American (AMR)
AF:
0.0184
AC:
280
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.0185
AC:
64
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00313
AC:
15
AN:
4798
European-Finnish (FIN)
AF:
0.00723
AC:
76
AN:
10516
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0168
AC:
1143
AN:
67964
Other (OTH)
AF:
0.0224
AC:
47
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
91
182
273
364
455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0138
Hom.:
10
Bravo
AF:
0.0127
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0163
EpiControl
AF:
0.0170

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Chédiak-Higashi syndrome Uncertain:1Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

not provided Benign:1
May 05, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
May 26, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
1.5
DANN
Benign
0.85
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33998267; hg19: chr1-235993709; API